Hem » Alla » Aktieprognos » Actinium Pharmaceuticals Inc. (Delaware) Common Stock Prognos

Actinium Pharmaceuticals Inc. (Delaware) Common Stock Prognos: Imorgon, Vecka, Månad, 5 år

Uppdaterad: April 22 · 2026 at 07:03 UTC
▲ +5.56%Market Cap $47.69M · Technical analysis Bullish · Focus area Price + volatility

Prognossammanfattning

TidsramFörväntat prisTidigareHistoriskaInsikt
Imorgon$1.55 +1.68%Igår$1.51 -0.71%Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.52 and targets $1.55 (+1.68%). The near-term read is upside; watch $1.57 / $1.47 because daily realized volatility is about 8.00%.
Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.52 and targets $1.55 (+1.68%). The near-term read is upside; watch $1.57 / $1.47 because daily realized volatility is about 8.00%.
Vecka$1.60 +5.23%Förra veckan$1.49 -2.19%The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.49 to $1.60 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.57 / $1.47 matter more than a single tick.
The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.49 to $1.60 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.57 / $1.47 matter more than a single tick.
Månad$1.69 +11.13%Förra månaden$1.45 -4.67%The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.69 (+11.13%), compared with the live reference near $1.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.69 (+11.13%), compared with the live reference near $1.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
år$1.82 +19.98%Förra året$1.39 -8.39%The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.82 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.82 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 år$2.14 +40.71%5 år sedan$1.26 -17.10%The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $2.14 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $2.14 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Imorgon$1.55 +1.68%
Igår$1.51 -0.71%
Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.52 and targets $1.55 (+1.68%). The near-term read is upside; watch $1.57 / $1.47 because daily realized volatility is about 8.00%.
Vecka$1.60 +5.23%
Förra veckan$1.49 -2.19%
The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.49 to $1.60 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.57 / $1.47 matter more than a single tick.
Månad$1.69 +11.13%
Förra månaden$1.45 -4.67%
The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.69 (+11.13%), compared with the live reference near $1.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
år$1.82 +19.98%
Förra året$1.39 -8.39%
The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.82 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 år$2.14 +40.71%
5 år sedan$1.26 -17.10%
The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $2.14 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Prisdiagram

HistoriskaPrognosHausseBaisse
$1.63$1.59$1.54$1.49$1.451W AgoNow7D F

Teknisk analys

SäljNeutralKöp
Bullish
2
Hausse
3
Neutral
0
Baisse

Nyckelindikatorer

IndikatorVärdeSignal
Price$1.52 Mid
Daily Change+5.56% Above
Volatility Cap20.0% Mid
Confidence69% Above
Data Sourcenasdaq-screener Mid

Historiska data

Current$1.52
Daily Change+5.56%
Market Cap$47.69M
Sourcenasdaq-screener
Current$1.52Daily Change+5.56%
Market Cap$47.69MSourcenasdaq-screener

Stöd- och motståndsnivåer

$1.47Support 1
$1.52Aktuell
$1.57Resistance 1
shield
Support and resistance are estimated from the trusted current price until deeper historical data is available.

Pris Milstolpar

Nyckelnivåer & historiskt sammanhang
Current$1.52Live reference price
Used as the anchor for generated forecast calculations.
Next Month$1.69Model projection+11.13%
Directional scenario based on capped drift.

Prognosnoggrannhet

Hur vår modell har presterat
69%
Riktad
Generated market-data forecast
This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.
📊
Vår algoritm omkalibreras varje vecka med den senaste prisåtgärden, volatilitetsregimen och indikatorsignaler. Noggrannheten varierar beroende på tidsram – kortsiktigt momentum är mer tillförlitligt än långsiktiga prognoser.
Short term
69%
Direction confidence
Long term
Lower
Forecast uncertainty rises with horizon

Investeringsscenarier

Om du investerar $1,000 i ATNM idag
Bullish Scenario
$1.60
+5.00% from current
Riktpris$1.60
ScenarioUpside momentum
Sannolikhet61%
Base Scenario
$1.69
+11.13%
Riktpris$1.69
ScenarioCapped drift
Sannolikhet69%
Bearish Scenario
$1.44
-5.00% from current
Riktpris$1.44
ScenarioVolatility drawdown
Sannolikhet31%
Grund: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Prognosfaktorer

Market Structure
Price structure reflects the latest momentum regime and support/resistance interaction.
Momentum Bullish · 74/100
24H drift+1.68%
7D drift+5.23%
30D drift+11.13%
Technical Signals
Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.
Mixed — Watching · 50/100
RSIn/a
MACDn/a
MA stackn/a
Macro Context
Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.
Risk-On Tentative · 70/100
1M outlook+11.13%
1Y outlook+19.98%
5Y outlook+40.71%

Vanliga frågor

Q What is the Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) forecast for tomorrow?
Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Actinium Pharmaceuticals Inc. (Delaware) Common Stock is projected near $1.55 versus the current reference around $1.52. That implies a modeled move of +1.68% over the next day, with realized prices still sensitive to intraday volatility.
Q What does the 7-day stock outlook suggest for ATNM?
The weekly Actinium Pharmaceuticals Inc. (Delaware) Common Stock model points to $1.60, which maps to an expected drift of +5.23% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.
Q How should I read the Actinium Pharmaceuticals Inc. (Delaware) Common Stock 1-month and 1-year targets?
The Actinium Pharmaceuticals Inc. (Delaware) Common Stock 1-month target is $1.69 (+11.13%), while the 1-year target is $1.82 (+19.98%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.
Q Why does the Actinium Pharmaceuticals Inc. (Delaware) Common Stock 5-year scenario differ from short-term rows?
The Actinium Pharmaceuticals Inc. (Delaware) Common Stock long-horizon scenario sits near $2.14 with a modeled change of +40.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.
Q Where are ATNM support and resistance zones right now?
For Actinium Pharmaceuticals Inc. (Delaware) Common Stock, nearest resistance is around $1.47, while nearest support is around $1.57. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.
Q How fresh is the Actinium Pharmaceuticals Inc. (Delaware) Common Stock market snapshot?
The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.